Form 4: Allarity Therapeutics CFO Receives RSU Grant

Allarity Therapeutics CFO Jeffrey S. Ervin was granted 150,000 restricted stock units as part of the company's equity incentive plan.

Summary

• CFO Jeffrey S. Ervin acquired 150,000 restricted stock units (RSUs) on January 28, 2026.
• The grant was issued under the Allarity Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan.
• The RSUs vest in three equal annual installments starting on the first anniversary of the grant date, contingent upon continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of executive interests with long-term shareholder value through equity-based compensation.
• Retention mechanism for key financial leadership via a three-year vesting schedule.

Negatives

• Potential for future shareholder dilution upon the vesting and settlement of the restricted stock units.

Risks

• Vesting is subject to the continued relationship of the CFO with the company, creating potential turnover risk if the executive departs before full vesting.

Future Outlook

The RSUs will vest in equal one-third installments on January 28, 2027, 2028, and 2029, provided the CFO remains with the company.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives in the biotechnology sector are standard practice for aligning management incentives with long-term clinical and commercial milestones.

Comparison to Industry Standards

• The use of a three-year vesting schedule is consistent with standard corporate governance practices for executive compensation in small-cap biotech firms.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual conversion of RSUs into common stock.

Next Steps

• Vesting of the first tranche of 50,000 RSUs on January 28, 2027.

Key Dates

Keywords

Allarity Therapeutics, ALLR, CFO, Insider Trading, Equity Incentive Plan, Restricted Stock Units